Vietnam MOH registration 220000022/PCBA-HD

HYBOGYN Contraceptive Tablet

VN: Viên đặt phụ khoa HYBOGYN

Vietnam·Risk Class TTBYT Loại A·PULIPHA003·Pulipha Pharmaceutical Corporation·Registered Feb 18, 2022

Registration details

Analysis ID: 220000022/PCBA-HD
Submission ID: 000.00.16.H23-220216-0001
Product Type: PULIPHA003

Company information

Manufacturer: Pulipha Pharmaceutical Corporation

Technical details

Intended Use: Supports and reduces the symptoms of fungal and bacterial infections in cases of vaginitis, cervical ectropion, etc. Helps women eliminate abnormal vaginal discharge and reduce itching and odor in the genital area. Helps to balance the pH in the vagina and promotes the regeneration of the epithelial cells in the genital area. Helps to tighten and strengthen the vagina, and improve its color and elasticity.

Dates and status

Registration Date: Feb 18, 2022

About this record

Access comprehensive regulatory information for HYBOGYN Contraceptive Tablet in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại A medical device is registered under number 220000022/PCBA-HD and manufactured by Pulipha Pharmaceutical Corporation.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.